Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-12-20
2000-04-04
Johnson, Nancy A
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 4241851, 435 691, 435 697, 530350, 530300, 530324, 530326, 530327, A61K 3804, C07K 708, C07K 14705, C07K 1900
Patent
active
060461586
ABSTRACT:
Novel genes expressed selectively by long-term dendritic cell (DC) lines (XS series) from murine epidermis which retain important features of resident epidermal Langerhans cells (LC) are provided. These genes encode distinct type II membrane-integrated polypeptides, each consisting of a cytoplasmic domain, a transmembrane domain, an extracellular connecting domain, and a C-terminal extracellular domain that exhibits significant homology to the carbohydrate recognition domains (CRD) of C-type lectins. Expression of both genes is highly restricted to cells of DC lineage (including epidermal LC). Thus, these genes encode new, DC-specific members of the C-type lectin family, now termed "DC-associated C-type lectin-1 and -2" (dectin-1 and dectin-2). Two isoforms of the dectin-1 molecule and five isoforms of the dectin-2 molecule have also been identified. The invention further provides His-tagged fusion proteins comprising 6.times. histidine and the extracellular domain of dectin-1 or dectin-2. Also provided are antibodies raised to synthetic peptides designed from the dectin-1 sequence or to the His-tagged fusion proteins described.
REFERENCES:
patent: 5434340 (1995-07-01), Krimpenfort et al.
patent: 5470952 (1995-11-01), Stahl
patent: 5530179 (1996-06-01), Terhorst et al.
patent: 5557032 (1996-09-01), Mak
Eckhardt, J. Bacteriol 169(9):4249 1987.
Showalter, Plant. Mol. Biol 16:547, 1991.
Drake Mol. Microbiol. 18(5):975, 1995.
Raaphorst, Eur J. Immunol 22:247, 1992.
Bobeck, Exp. Parisitol 72:381, 1991.
Cameron, J. Bacteriol 173:6066, 1991.
Genebank (1998) Accession No. S48368, A41970 A44922, F69713, A22867, A14997, A12030, A34412, S39414, A00925, A22867, C69549, A25285, A28013.
Falk, Nature 351:290, 1991.
Ariizumi, FASEB 10(6):A1213 Jun. 2-6, 1996.
Ariizumi, Bergstresser, and Takashima, "Cloning of Novel C-Type Lectins That Are Expressed Selectively By Dendritic Cells," The Journal of Investigative Dermatology, 106(4):814, Abstract No. 52, Apr. 1996.
Benzouska, "C-Type Lectins of Natural Killer Cells: Carbohydrate Ligands and Role in Tumor Cell Lysis," Biochemical Society Transactions, 24:156-161, 1996.
Benzouska et al., "Rat Natural Killer Cell Antigen, NKR-P1, Related to C-Type Animal Lectins Is a Carbohydrate-Binding Protein," The Journal of Biological Chemistry, 269(24):16945-16952, Jun. 1994.
Chang et al., "Molecular Characterization of Human CD94: A Type II Membrane Glycoprotein Related to the C-Type Lectin Superfamily," Eur. J. Immunol., 25:2433-2437, 1995.
Cherayil, Weiner and Pillai, "The Mac-2 Antigen Is a Galactose-Specific Lectin That Binds IgE," J. Exp. Med., 170:1959-1972, Dec. 1989.
Erard et al., "Interleukin 2 Is Both Necessary and Sufficient For the Growth and Differentiation of Lectin-Stimulated Cytolytic T Lymphocyte Precursors," The Journal of Immunology, 134(3):1644-1652, Mar. 1985.
Ezekowitz, Day, and Herman, "A Human Mannose-Binding Protein Ia an Acute-Phase Reactant That Shares Sequence Homology with other Vertebrate Lectins," J. Exp. Med., 167:1034-1046, Mar. 1988.
Hamann, Fiebig, and Strauss, "Expression Cloning of the Early Activation Antigen CD69, A Type II Intgral Membrane protein with a C-Type Lectin Domain," The Journal of Immunology, 150(11):4920-4927, Jun. 1993.
Lanier, Chang and Phillips, "A Disulfide.sub.-- Linked Homodimer of the C-Type Lectin Superfamily Expressed by a Subset of NK and T Lymphocytes," The Journal of Immunology, 153:2417-2428, 1994.
Licastro, Davis, and Morini, "Lectins and Superantigens: Membrane Interactions of These Compounds with T Lymphocytes Affect Immune Responses," Int. J. Biochem., 25(6):845-852, 1993.
Lopez-Cabrera et al., "Molecular Cloning, Expression, and Chromosomal Localization of the Human Earliest Lymphocyte Activation Antigen AIM/CD69, a New Member of the C-Type Animal Lectin Superfamily of Signal Transmitting Receptors," J. Exp. Med., 178:537-547, Aug. 1993.
Roosnek, Brouwer, and Aarden, "T Cell Triggering By Lectins II. Stimuly For Induction of Interleukin 2 Responsiveness and Interleukin 2 Production Differ Only in Quantitative Aspects," Eur. J. Immunol., 15:657-661, 1985.
Sowalsky and Fox, "Pattern of Lectin Binding to Murine T Lymphocytes," Immunology, 75:92-98, 1992.
Steinman and Swanson, "The Endocytic Activity of Dendritic Cells," J. Exp. Med., 182:283-288, Aug. 1995.
Suzuki et al., "Molecular Cloning and Expression of cDNA Encoding Human Macrophage C-Type Lectin," The Journal of Immunology, 156:128-135, 1996.
Ariizumi Kiyoshi
Takashima Akira
Board of Regents The University of Texas Systems
Johnson Nancy A
LandOfFree
Unique dendritic cell-associated C-type lectins, dectin-1 and de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unique dendritic cell-associated C-type lectins, dectin-1 and de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unique dendritic cell-associated C-type lectins, dectin-1 and de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-364989